Edmund K Waller Selected Research

Antilymphocyte Serum (Anti-Thymocyte Globulin)

1/2020	Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.
7/2003	Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edmund K Waller Research Topics

Disease

48	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2023 - 01/2002
47	Neoplasms (Cancer) 04/2024 - 04/2003
33	Leukemia 12/2023 - 04/2003
23	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2002
19	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 01/2007
19	Infections 01/2023 - 02/2002
15	Lymphoma (Lymphomas) 01/2020 - 12/2004
14	Bronchiolitis Obliterans Syndrome 01/2023 - 05/2007
14	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 11/2012
13	Multiple Myeloma 12/2023 - 12/2005
13	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 01/2007
9	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 10/2016
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 10/2006
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2023 - 03/2015
6	Thrombocytopenia (Thrombopenia) 01/2019 - 09/2002
5	Pathologic Complete Response 12/2022 - 02/2012
5	Pain (Aches) 12/2020 - 01/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 05/2014
5	Breast Neoplasms (Breast Cancer) 01/2019 - 09/2002
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2022 - 04/2013
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 04/2010
4	Melanoma (Melanoma, Malignant) 01/2019 - 04/2003
4	Hodgkin Disease (Hodgkin's Disease) 01/2016 - 10/2006
3	Myocardial Infarction 06/2023 - 01/2018
3	Sickle Cell Anemia (Hemoglobin S Disease) 01/2023 - 03/2002
3	Neutropenia 12/2022 - 04/2009
3	Opportunistic Infections (Opportunistic Infection) 01/2022 - 04/2004
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 09/2015
3	Inflammation (Inflammations) 11/2021 - 11/2017
3	Ischemia 01/2020 - 10/2016
3	Peripheral Arterial Disease 01/2020 - 07/2009
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2014 - 01/2007
2	Myeloid Leukemia (Leukemia, Myelocytic) 12/2023 - 06/2012
2	Disease Progression 10/2021 - 01/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

13	AntigensIBA 01/2021 - 12/2002
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2023 - 06/2007
12	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019 - 12/2004
10	tisagenlecleucelIBA 01/2023 - 12/2018
10	Busulfan (Busulfex)FDA Link 01/2020 - 01/2002
9	Peptides (Polypeptides)IBA 04/2024 - 04/2004
9	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2023 - 12/2002
9	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2018
7	cytidylyl-(3'-5')-cytidine (CpC)IBA 06/2023 - 10/2016
6	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 04/2024 - 12/2016
6	AntibodiesIBA 10/2022 - 12/2002
6	fludarabineIBA 01/2020 - 10/2003
6	Calcineurin InhibitorsIBA 10/2019 - 10/2016
6	Etoposide (VP 16)FDA LinkGeneric 01/2016 - 10/2006
5	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 01/2002
5	plerixafor FDA Link 01/2019 - 10/2011
5	CytokinesIBA 12/2018 - 04/2003
4	VaccinesIBA 12/2023 - 08/2005
4	Rituximab (Mabthera)FDA Link 12/2022 - 01/2007
4	EpitopesIBA 01/2021 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2018
4	CXC ChemokinesIBA 08/2020 - 10/2017
4	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 10/2010
4	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 01/2002
4	(VIP-neurotensin) hybrid antagonistIBA 01/2017 - 01/2013
4	Bortezomib (Velcade)FDA Link 02/2015 - 12/2005
4	HLA Antigens (Human Leukocyte Antigens)IBA 12/2013 - 01/2002
4	Antiviral Agents (Antivirals)IBA 11/2011 - 12/2003
3	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA 04/2024 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 06/2023 - 04/2013
3	ibrutinibIBA 01/2023 - 11/2017
3	Prednisone (Sone)FDA LinkGeneric 01/2023 - 11/2018
3	Sirolimus (Rapamycin)FDA Link 01/2023 - 04/2016
3	SteroidsIBA 01/2022 - 04/2009
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2020 - 10/2017
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2019 - 07/2014
3	LigandsIBA 08/2015 - 06/2012
3	amotosalenIBA 05/2008 - 12/2003
2	Lenalidomide (CC 5013)FDA Link 12/2023 - 10/2020
2	trans-crotonin (CTN)IBA 12/2023 - 11/2018
2	Proteasome InhibitorsIBA 12/2022 - 12/2005
2	NeuropeptidesIBA 10/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Interleukin-12 (IL 12)IBA 01/2022 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 12/2005
2	Abatacept (Orencia)FDA Link 10/2021 - 11/2013
2	IndolesIBA 01/2021 - 12/2018
2	Minor Histocompatibility AntigensIBA 01/2021 - 12/2009

Therapy/Procedure

40	Therapeutics 01/2023 - 04/2003
31	Transplantation 09/2023 - 02/2002
25	Cell Transplantation 03/2024 - 04/2010
23	Hematopoietic Stem Cell Transplantation 01/2023 - 07/2009
19	Stem Cell Transplantation 12/2022 - 06/2007
19	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019 - 01/2002
17	Drug Therapy (Chemotherapy) 10/2021 - 09/2002
11	Homologous Transplantation 01/2018 - 04/2004
10	Immunotherapy 01/2022 - 04/2004
6	Blood Component Removal (Apheresis) 01/2019 - 12/2004
6	Hematopoietic Stem Cell Mobilization 01/2017 - 10/2006
5	Autologous Transplantation 04/2015 - 10/2006
4	Photopheresis 02/2021 - 11/2010
3	Salvage Therapy 12/2020 - 10/2006
3	Radiotherapy 12/2020 - 06/2014
3	Haploidentical Transplantation 10/2019 - 06/2012
3	Erythrocyte Transfusion 01/2019 - 02/2015